From September 28, 2022 to September 30, 2022, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for KRW 0 million under the buyback announced on September 28, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28,950 KRW | +0.52% | +1.22% | +4.32% |
2023 | Daihan Pharmaceutical Co.,Ltd.(KOSDAQ:A023910) dropped from S&P Global BMI Index | CI |
2023 | Daihan Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.32% | 125M | |
+21.63% | 44.12B | |
+22.99% | 22.71B | |
+18.22% | 15.15B | |
+12.66% | 13.61B | |
+60.18% | 13.34B | |
-8.35% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.92% | 5.63B |
- Stock Market
- Equities
- A023910 Stock
- News Daihan Pharmaceutical Co.,Ltd.
- Tranche Update on Daihan Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on September 28, 2022.